AV-299

BIOLOGICAL2 trials

Sponsors

AVEO Pharmaceuticals, Inc.

Conditions

Liver MetastasesLymphomasMalignant Solid TumorMalignant Solid TumourMultiple Myeloma

Phase 1

A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma

CompletedNCT00725634

AVEO Pharmaceuticals, Inc.Lymphomas, Malignant Solid Tumor, Multiple Myeloma

Start: 2008-09-30End: 2013-12-31Updated: 2014-01-27

A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases

CompletedNCT00969410

AVEO Pharmaceuticals, Inc.Liver Metastases, Malignant Solid Tumour

Start: 2009-08-31End: 2011-03-31Updated: 2012-04-12